This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Accelrys European Science Symposium Highlights Advanced Data Analysis And Predictive Science

SAN DIEGO, June 11, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, announced its first European Science Symposium with a focus on advancing scientific innovation through improved predictive science and data analysis. Taking place on June 20 at the Sheraton Brussels Hotel, this free event provides the opportunity for scientists to hear how academic and industry experts are addressing today's most difficult and important scientific challenges with advanced modeling, simulation and data analysis software solutions.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-european-science-symposium-highlights-advanced-data-analysis-and-predictive-science-158259605.html

The Science Symposium includes speakers from Accelrys and ABB ( Sweden), ETH ( Zurich), EsbaTech ( Switzerland), European Bioinformatics Institute and University of Dundee (UK), FMP and Fraunhofer IFAM ( Germany), Universite de Mons ( Belgium), Universidad de Navarra ( Spain) and Institut de Recherches Servier, Discngine and Universite de Strasbourg ( France).

"Recent years have seen a big shift in the focus of pharmaceutical drug research with an increased emphasis on more efficient innovation," said Dr. Hugues-Olivier Bertrand, Sr. Director of Modeling and Simulation at Accelrys.  "Leveraging Accelrys' deep domain expertise in chemistry, biology and materials science, predictive science and informatics, the Science Symposium will explore new data analysis and modeling and simulation solutions that are accelerating the innovation cycle with compelling case studies drawn from the European research community."

The European Science Symposium offers three dedicated tracks focusing on:

  • Scientific Data AnalysisThis track focuses on the use of Pipeline Pilot and the scientific Component Collections that underpin Accelrys Enterprise Platform to solve problems spanning cheminformatics, bioinformatics (including Next Generation Sequencing), image analysis, statistical analysis and text analytics.
  • Life Sciences Modeling and SimulationThis track focuses on the use of Accelrys Discovery Studio software in the discovery and development of macromolecule therapeutics and small molecule drugs. This track also features a demonstration of the upcoming Discovery Studio release along with case studies on the design and development of antibody drugs and lead optimization of small molecules.
  • Materials Science Modeling and SimulationThis track focuses on the use of Accelrys Materials Studio software in the research and development of new materials and the optimization of existing materials and formulations. Case studies will cover topics such as polymer, formulation and catalysis modeling.

For registration and accommodation information including a detailed agenda with track and speaker descriptions, visit the European Science Symposium website.

About Accelrys, Inc.Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.

SOURCE Accelrys, Inc.

Stock quotes in this article: ACCL 
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs